Clinical trial Recruiting at 1 site Interventional Ages 65 to 95

Dressing Type and Change Frequency for Healing Wounds After Hip Replacement

Official title: Impact of Dressing Type and Dressing Change Frequency on Surgical Wound Healing Following Primary Total Hip Arthroplasty

Run by Clinical Center of Vojvodina · NCT07655388 · Data updated 2026-11-12

This study tests whether a VACUTEX capillary-action dressing or standard dressings with different change intervals help wounds heal faster after a primary total hip arthroplasty in adults 65 and older.

Quick facts

Study typeInterventional
Ages65 Years to 95 Years
SexAll
Enrollment90 (estimated)
SponsorClinical Center of Vojvodina
Academic / other
Locations1 site (Novi Sad)
StatusRecruiting
StartedJuly 1, 2026
Main results expectedAugust 1, 2026
Study endsNovember 1, 2026
Registry record updatedJuly 10, 2026
Trial IDNCT07655388 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 65 or older undergoing primary THA with closed incisions and able to consent.

Probably not a fit

Patients with revision hip surgery, active infection, severe immunosuppression, or dressings/allergies to study materials may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective, randomized trial compares three wound care strategies after primary total hip arthroplasty. Participants are assigned to VACUTEX dressing changed every 4 days, or standard dressings with Octenisept solution changed every 3 days or every 2 days. Primary outcome is time to complete wound epithelialization; secondary outcomes include wound complications, pain, wound temperature, exudate pH, hospital stay, and time to suture removal. Data will include baseline demographics and preoperative labs to characterize the population. The study is conducted at the Clinic for Orthopedic Surgery and Traumatology, University Clinical Centre of Vojvodina, with 90 total participants in three parallel groups using block randomization.

Why it matters

Potential benefit: If successful, dressing choice and timing could shorten healing time and reduce wound complications after hip replacement.

How similar studies have gone: Previous wound care studies suggest dressing type and change frequency can influence healing, but data in primary THA patients are limited, making this approach relatively novel in this context.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients scheduled for primary total hip arthroplasty (THA)
* Age ≥ 65 years
* Ability to provide informed consent
* Patients with closed surgical incision suitable for standard postoperative wound care

Exclusion Criteria:

* Revision hip arthroplasty
* Active infection at the time of surgery
* Immunosuppressive therapy or severe immunodeficiency
* Known allergy to dressing materials used in the study
* Severe peripheral vascular disease affecting wound healing
* Inability to comply with follow-up protocol

Where it's running

  • Clinic for Orthopedic Surgery and Traumatology, University Clinical Center of Vojvodina
    Novi Sad, Serbia
    Recruiting

Study contacts

  • Principal investigator: Andrijana Ćorić — Faculty of Mediicne, University of Novi Sad
  • Study coordinator: Andrijana Ćorić, MScN
  • Email: 912007d23@mf.uns.ac.rs
  • Phone: +381611810756

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Suzetrigine for pain control after primary total hip replacement

    This will test whether taking Suzetrigine before surgery and for seven days afterward reduces opioid use and improves pain control in adults having a primary total hip replacement.

    Recruiting Phase 3 Hospital for Special Surgery, New York · New York, New York · NCT07226700

  • Choose to Move Replacement Ready for OA patients waiting for hip or knee replacement

    This program tests a tailored, online version of a 3-month activity and social-connection plan for older adults with hip or knee osteoarthritis who are waiting for joint replacement surgery to see if it improves physical activity and health while they wait.

    Recruiting University of British Columbia · Vancouver, British Columbia · NCT07696650

  • Foot core exercises after total hip replacement

    This trial tests whether adding foot core exercises to the usual hip rehab helps improve foot and leg strength, balance, and foot structure in people who recently had a hip replacement.

    Recruiting Hacettepe University · Ankara, Altındağ · NCT07665801

  • Tipmed™ Primary Hip Prosthesis: 24-Month Post-Market Follow-Up in Adults

    This PMCF study tests the safety and 24‑month performance of the Tipmed hip prosthesis in adults undergoing primary hip replacement.

    Recruiting at 4 sites TIPMED Medical Device Manufacturing Ltd. Co. · Balıkesir and 3 other locations · NCT07651735

  • Post-op prednisone vs standard steroid regimen after knee or hip replacement

    This study tests a 5-day oral prednisone course after knee or hip replacement to see if pain, swelling, and glucose control are better or different than the usual intraoperative steroid approach.

    Recruiting Phase 4 Columbia University · New York, New York · NCT07630896

  • Additional HI-PEMF therapy after total hip replacement

    This study tests whether high-intensity pulsed electromagnetic fields can help reduce pain and improve daily function after hip replacement in adults who just had the surgery.

    Recruiting National Taiwan University Hospital · Taipei · NCT07564427

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.